STOCK TITAN

Chime Financial, Inc. (CHYM) SEC Filings

CHYM NASDAQ

Welcome to our dedicated page for Chime Financial SEC filings (Ticker: CHYM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Chime Financial, Inc. filings document the regulatory record for a Nasdaq-listed financial technology company offering digital banking access, payments products, and liquidity tools through bank partners. The company’s 8-K reports furnish quarterly and annual financial results, related earnings materials, and other corporate events.

Chime’s filings also cover Class A common stock repurchase authorizations, board actions, exhibits, and Inline XBRL cover-page data. Its proxy materials address shareholder voting matters, board governance, executive compensation, equity awards, and related annual meeting disclosures.

Rhea-AI Summary

Chime Financial, Inc. (CHYM) director and co-founder Ryan A. King reported a series of transactions on September 9, 2026 involving Class A and Class B Common Stock. A block of 34,941 shares of indirectly held Class B Common Stock was converted into an equal number of Class A shares, and 42,421 Class A shares were then sold at a weighted average price of $35.1476 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2025. Following these transactions, King continues to hold derivative interests in multiple blocks of Class B shares convertible into Class A shares, as well as 116,667 Class A shares held directly, which include restricted stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) received a Rule 144 notice for a proposed resale of its common stock by shareholder Menlo Inflection II, L.P. The filing covers up to 569,755 shares of common stock, to be sold through Merrill Lynch on Nasdaq, with an indicated date of sale of September 10, 2026.

The shares were originally acquired from the issuer in a private placement on May 16, 2018. The notice lists an aggregate market value of $19,685,035.25 for the securities and references 347,019,852 shares outstanding of Chime common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) received a notice that Menlo Entrepreneurs Inflection Fund, L.P. intends to sell up to 3,765 shares of its common stock under Rule 144. The shares are to be sold through Merrill Lynch and have an aggregate market value of approximately $130,080.75 as listed.

The shares were originally acquired from the issuer in a private placement for cash on May 16, 2018. The proposed Rule 144 sale date referenced in the notice is September 10, 2026, with trading on Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Chime Financial, Inc. (CHYM) received a Rule 144 notice covering a proposed sale of 5,793 shares of common stock by MM Inflection, L.P., to be sold through Merrill Lynch on Nasdaq on or after September 10, 2026. These shares were acquired from the issuer in a private placement on May 16, 2018 for cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) is the issuer of common stock for which Crosslink Crossover Fund VII has filed a notice of proposed sale under Rule 144, covering up to 53,508 shares of common stock. The filing lists an aggregate market value of approximately $1,773,661.78 for these shares, with an intended sale date of September 10, 2026 on NASDAQ through Morgan Stanley Smith Barney LLC. The notice states that Chime Financial had 347,019,852 shares outstanding of common stock at the time referenced. The shares were originally acquired on April 19, 2016 in a private acquisition from the issuer or an affiliate, paid for in cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) has a notice of proposed sale of restricted shares filed under Rule 144 on behalf of Crosslink Crossover Fund VI. The fund plans to sell 93,492 shares of common stock, with an indicated aggregate market value of $3,099,035.42, through Morgan Stanley Smith Barney LLC on NASDAQ around September 10, 2026.

The shares were originally acquired in a private acquisition from the issuer or an affiliate on October 27, 2014 for cash. Chime Financial reports that 347,019,852 shares of common stock were outstanding at the time referenced in the notice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Chime Financial, Inc. (CHYM) disclosed that Chief Accounting Officer Asmerom Amine reported selling a total of 19,505 shares of Class A Common Stock on September 8, 2026 in two transactions, reported as sales in open market or private transactions, under a Rule 10b5-1 trading plan.

The sales covered 10,000 shares at a weighted average price of $32.5428 per share and 9,505 shares at a weighted average price of $33.3615 per share, each executed across multiple prices within disclosed ranges. A footnote states that certain of the reported securities are restricted stock units (RSUs).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) has a notice of proposed sale under Rule 144 filed on behalf of KING FAMILY TRUST. The trust plans to sell up to 42,421 shares of common stock through Morgan Stanley Smith Barney LLC, with shares sourced from restricted stock units and previously exercised stock options. The notice also lists recent 10b5-1 plan sales totaling 375,000 shares over the past three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Chime Financial, Inc. (CHYM) is the issuer for a planned resale of its common stock under Rule 144 by the 2019 Newcomb Fox Family Trust, an account associated with an officer. The notice covers up to 42,420 shares of common stock, held at Morgan Stanley Smith Barney LLC.

The trust’s securities were acquired upon vesting of restricted stock units during the period from November 15, 2025 through August 15, 2026. In the past three months, the trust has already executed Rule 10b5-1 sales totaling 90,000 shares of common stock on August 6, 2026 (65,000 shares for $1,961,000.00) and August 24, 2026 (25,000 shares for $824,457.00).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Chime Financial, Inc. (CHYM) agreed to acquire Central Service Corporation, parent of Stride Bank, N.A., for $590 million in cash, with the deal structured via a merger of a Chime subsidiary into CSC. Stride will become Chime Bank, N.A., a wholly owned subsidiary, and Chime will become a bank holding company after closing.

The transaction value represents ~1.5x tangible book value for Stride, which is described as profitable and well‑capitalized, and is expected to be immediately accretive to Chime’s EPS with more than $100 million in net synergies from sponsor bank fee savings, lending expansion and lower funding costs. Chime plans to fund the purchase from cash on its balance sheet and does not anticipate incremental capital. The deal, unanimously approved by both boards, is expected to close in the first half of 2027, subject to Federal Reserve and OCC approvals and other customary conditions. Chime raised guidance, now expecting Q3 2026 revenue of $705 million (about 30% year‑over‑year growth) and full‑year 2026 revenue of $2.76–$2.77 billion with adjusted EBITDA margins of roughly 17–18%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.93%
Tags
current report

FAQ

How many Chime Financial (CHYM) SEC filings are available on StockTitan?

StockTitan tracks 135 SEC filings for Chime Financial (CHYM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Chime Financial (CHYM)?

The most recent SEC filing for Chime Financial (CHYM) was filed on September 10, 2026.